FDA Update FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products The FDA just announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, an interactive tool designed to facilitate the public’s ability to query real-time adverse event data on cosmetic products. The user-friendly platform allows users to
FDA ensures safety of Cosmetic Products Using Adverse Event Reports to Monitor Cosmetic Safety!! Cosmetics are a broad category of products that, by law, are intended to, among other things, cleanse or alter appearance. Per Linda Katz, M.D., MPH, director of the FDA’s Office of Cosmetics and Colors “Every person uses some cosmetic product on
Since the issuance of 2013 revised FDA Guidance “Cosmetic Good Manufacturing (GMP) Guidelines/Inspection Checklist”, FDA enforcement of cosmetic manufactures has been steadily on the rise. FDA has always used warning letters as an effective compliance mechanism to let companies know that they have violated the laws and to tell them what corrective action they need
FDA Issues Warning Letters for making drug claims on Cosmetic Products FDA has always used warning letters as an effective compliance mechanism to let companies know that they have violated the laws and to tell them what corrective action they need to take. Over the years, FDA has issued a number of warning letters directed
On April 20th of this year two senators from Maine and California introduced the Personal Care Products Safety Act . If passed, this bill would expand FDA’s authority over cosmetic products sold in the United States. The changes are similar to that of requirements for nonprescription drugs including cosmetic GMP’s and ingredient review, establishment and
mdi Consultants